UMIN-CTR History

Name：　　UMIN ID：

Unique ID issued by UMIN	UMIN000013202
Receipt number	R000015399
Scientific Title	A phaseI/II study of Erlotinib/Carboplatin/Pemetrexed/Bevacizumab in chemotherapy-naive patients with EGFR mutation positive advanced non-squamous non-small-cell lung cancer
Date of disclosure of the study information	2014/02/19
Last modified on	2014/02/19 20:42:37

---